Greater Trochanteric Pain Syndrome Clinical Trial
Official title:
Clinical Characteristics and Subgroups in Greater Trochanteric Pain Syndrome
This cross-sectional study will gather participant data from clinical assessment and questionnaires for individuals with a clinical diagnosis of Greater Trochanteric Pain Syndrome.
Greater trochanteric pain syndrome (GTPS) is characterised by pain over and around the greater trochanter and is primarily due to gluteal tendinopathy. Pain associated with GTPS can affect an individual's ability to perform daily activities while also having a negative impact on sleep, work and participation in sport. Quality of life is often impaired and comparable to severe hip osteoarthritis. A significant number report chronic pain and disability with 29% and 45% of individuals continuing to experience pain at five and 11-year follow-up respectively. Exercise programmes which specifically target the gluteal muscles and tendons are normally the first-line treatment for GTPS, however 20-50% of individuals do not fully recover within 12 months with this intervention. The reasons for this poor response remain unclear but may be associated with the presence of certain clinical characteristics. Diabetes, obesity, co-existing musculoskeletal disorders, psychological factors and physical activity level may affect prognosis and treatment outcome in GTPS. Co-existing low back and/or hip joint pain is common in this population and a higher number of pain sites has been associated with poorer outcome in other musculoskeletal conditions. In clinical trials, participants with GTPS are often grouped together regardless of individual clinical characteristics. Current treatment strategies appear inadequate for a proportion of patients with this condition meaning alternative options are required to achieve a positive clinical outcome. Subgroups of patients within the same condition have been identified in low back pain, osteoarthritis and patellofemoral pain. Thus, it is important to look for subgroups within the clinically diagnosed GTPS population. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT03479190 -
Platelet Rich Plasma Versus Placebo for the Treatment of Greater Trochanteric Pain Syndrome (HiPPO Trial)
|
N/A | |
| Terminated |
NCT05486078 -
Evaluation of the Efficacy of the Use MD Tissue Collagen Medical Device in the Infiltrative Treatment of Greater Trochanter Pain Syndrome (GTPS)
|
N/A | |
| Recruiting |
NCT05086926 -
Feasibility of Home Exercises With the Addition of a Corticosteroid Injection in Patients With Lateral Hip Pain in General Practice
|
N/A | |
| Not yet recruiting |
NCT05076994 -
The PET Project: Patient Education Tool for Home Exercise
|
N/A | |
| Recruiting |
NCT05516563 -
LEAP-Ireland Feasibility Trial of Exercise and Education for Gluteal Tendinopathy
|
N/A | |
| Not yet recruiting |
NCT02031367 -
Efficacy of Platelet Rich Plasma vs. Corticosteroid Injections for Treating Greater Trochanteric Pain Syndrome
|
Phase 0 | |
| Completed |
NCT01642043 -
Point-of-Care Ultrasound in Greater Trochanteric Pain Syndrome
|
||
| Not yet recruiting |
NCT05710627 -
Evaluation of TENEX for Greater Trochanteric Pain Syndrome (GTPS)
|
N/A | |
| Recruiting |
NCT06241872 -
Evaluation of the Effectiveness of Dry Needling Treatment in Patients Diagnosed With Greater Trochanteric Pain Syndrome
|
N/A | |
| Completed |
NCT03720587 -
The Experiences of Patients With Greater Trochanteric Pain Syndrome.
|
||
| Completed |
NCT04537091 -
Radial Extracorporeal Shock Wave Therapy Versus Platelet-rich Plasma Injection for Greater Trochanteric Pain Syndrome
|
N/A | |
| Completed |
NCT01562366 -
Research Study to Compare the Addition of Topaz Micro Debridement to the Standard of Care Surgery
|
N/A |